„We are looking forward to work within the network of InfectoGnostics Research Campus. Our platform is an ideal complement to the technology portfolio of InfectoGnostics, as it combines both therapy and diagnostics in a theranostic approach“, states Dr. Marc Lehmann, CEO of SmartDyeLivery. „The combination of a precisely targeted and efficient delivery of drugs with lower side effects, together with a tailored diagnostic is an ideal means for an improved and individualized patient care.“
Professor Juergen Popp, managing board spokesman of InfectoGnostics adds: „We are pleased to welcome the recently founded company SmartDyeLivery as partner of our InfectoGnostics Research Campus. Smart DyeLivery’s platform technology can be applied to various fields of applications, including diagnosis and treatment of infections with antibiotic-resistant pathogens, which are in the center of interest of our Research Campus.”
InfectoGnostics – Research Campus Jena
The InfectoGnostics Research Campus is a public-private partnership developing new methods in infection diagnostics. In a triad of technology, application and production, more than 30 partners from science, medicine and industry are developing marketable solutions for rapid and cost-effective on-site analysis (point-of-care testing) of infections. InfectoGnostics is supported by the German Federal Ministry of Education and Research within the funding initiative "Research campus - Public-private Partnership for Innovation" and with additional funding by the Land of Thuringia. Half of the budget is financed by the InfectoGnostics partners.
Further info on SmartDyeLivery: